Pronounced: LOO-koh-en-sef-ah-LOP-ah-thee
PML is a rare progressive disease of the nervous system. It is caused by a viral infection of the cells that produce myelin.
The Neuron
Copyright © Nucleus Medical Media, Inc.
PML is caused by a papovavirus, known as JC virus. Most people get this infection in childhood, and it produces no illness. It reactivates later in life in people who have a suppressed immune system (eg, HIV/AIDS ).
The most common risk factor is having HIV/AIDS. PML is rarely associated with:
If you experience any of these symptoms, do not assume it is due to PML. These symptoms may be caused by other conditions. Symptoms progress over weeks and include:
Your doctor will ask about your symptoms and medical history. She will also do a physical exam. Tests may include:
Treatment focuses on strategies to improve the immune system. If you have HIV, your doctor will most likely prescribe antiretroviral medicine to treat this condition. If PML has resulted from the drug natalizumab, your doctor will have you stop taking this drug and may recommend a plasma exchange to remove the drug from your blood system.
RESOURCES:
AIDS.org
http://www.aids.org/
National Organization for Rare Disorders
http://www.rarediseases.org/
CANADIAN RESOURCES:
Canadian AIDS Society
http://www.cdnaids.ca/
Canadian Organization for Rare Disorders
http://www.cord.ca/
References:
AETC National Resource Center. Progressive multifocal leukoencephalopathy. AETC National Resource Center website. Available at: http://www.aids-ed.org/aidsetc?page=cm-528_pml . Accessed November 10, 2010.
Greenlee JE, Roos RP. MedLink website. Available at: http://www.medlink.com . Accessed March 10, 2012.
National Institute of Neurological Disorders and Stroke. Progressive multifocal leukoencephalopathy information page. National Institute of Neurological Disorders and Stroke website. Available at http://www.ninds.nih.gov/disorders/pml/pml.htm . Updated February 10, 2012. Accessed March 10, 2012.
Progressive multifocal leukoencephalopathy. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/what.php . Updated May 27, 2010. Accessed November 10, 2010.
Warnke C, Menge T, Hartung HP, et al. Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided? Arch Neurol . 2010;67(8):923-30.
Last reviewed March 2013 by Rimas Lukas, MD
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © 2012 EBSCO Publishing All rights reserved.